Search Advanced

AIMS Public Health

2014, Volume 1, Issue 4: 241-255. doi: 10.3934/publichealth.2014.4.241
Previous Article Next Article
Brief report

Tuberculosis in Canada: Detection, Intervention and Compliance

  • 1.
    Centre for Disease Modelling, York Institute for Health Research, York University, Toronto, Canada;
  • 2.
    Public Health Ontario, Toronto, Canada;
  • 3.
    Institute of Health Policy, Management and Evaluation, University of Toronto, Canada;
  • 4.
    Institute for Clinical Evaluative Sciences, University of Toronto, Canada;
  • 5.
    Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Canada;
  • 6.
    Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Canada;
  • 7.
    Department of Mathematics and Statistics, York University, Toronto, Canada
  • Received: 29 July 2014 Accepted: 22 October 2014 Published: 24 November 2014

  • This paper provides an overview of the current state of TB in Canada by referencing information presented at the workshop, “Tuberculosis: Detection, Prevention, and Compliance.” The workshop took place on November 14 and 15, 2012 in Ottawa. The workshop was organized by the Centre for Disease Modeling and the Public Health Agency of Canada as a two-day knowledge translation event that was comprised of scientific and policy focused presentations designed to address four key objectives: (1) Evaluate the success of current tuberculosis (TB) health policies and control strategies in Canada and for specific Canadian sub-populations; (2) Determine the impact of detection, intervention, compliance, and education strategies in terms of TB incidence and prevalence; (3) Develop targets for future interventions by identifying key characteristics of TB epidemics that impact the success of TB health policies and control strategies; (4) Leverage our existing ties with public health decision makers, aboriginal health organizations, and organizations serving the homeless to develop a research community that is based on close collaboration, and will foster national TB control efforts. The workshop elicited robust discussions between experts from a variety of academic disciplines and government officials. A summary of the information presented, comments shared, and questions posed, will provide a comprehensive understanding of the status of TB in Canada and future directions to be taken for improved control of the disease.

    Citation: Katya Richardson, Beate Sander, Hongbin Guo, Amy Greer, Jane Heffernan. Tuberculosis in Canada: Detection, Intervention and Compliance[J]. AIMS Public Health, 2014, 1(4): 241-255. doi: 10.3934/publichealth.2014.4.241

    Related Papers:

  • This paper provides an overview of the current state of TB in Canada by referencing information presented at the workshop, “Tuberculosis: Detection, Prevention, and Compliance.” The workshop took place on November 14 and 15, 2012 in Ottawa. The workshop was organized by the Centre for Disease Modeling and the Public Health Agency of Canada as a two-day knowledge translation event that was comprised of scientific and policy focused presentations designed to address four key objectives: (1) Evaluate the success of current tuberculosis (TB) health policies and control strategies in Canada and for specific Canadian sub-populations; (2) Determine the impact of detection, intervention, compliance, and education strategies in terms of TB incidence and prevalence; (3) Develop targets for future interventions by identifying key characteristics of TB epidemics that impact the success of TB health policies and control strategies; (4) Leverage our existing ties with public health decision makers, aboriginal health organizations, and organizations serving the homeless to develop a research community that is based on close collaboration, and will foster national TB control efforts. The workshop elicited robust discussions between experts from a variety of academic disciplines and government officials. A summary of the information presented, comments shared, and questions posed, will provide a comprehensive understanding of the status of TB in Canada and future directions to be taken for improved control of the disease.


    加载中
    [1] Dubos RJ (1951) The white plague: tuberculosis, man, and society. Boston: Little, Brown and Company.
    [2] Daniel TM (2006) The history of tuberculosis. Respir Med 100(11): 1862-1870.
    [3] 14. Dawar M, Clark M, Deeks SL, et al. (2004) A fresh look at an old vaccine: does BCG have a role in 21st century Canada? Int J Circumpolar Health 62): 230-236.
    [4] 15. Sandy J, Richardson R, Warman A, et al. (2007) Mycobacterium tuberculosis infection in first nations preschool children in Alberta Implications for BCG (Bacilli Calmette-Guérin) vaccine withdrawal. Can J Public Health 98(2): 116-120.
    [5] 17. Wong T (2012) TB: public health implementation science. Tuberculosis in Canada: detection, intervention and compliance. Ottawa: Centre for Disease Modeling and the Public Health Agency of Canada.
    [6] 18. Wobeser W (2012) Interferon Gamma Release Assay (IGRA) Screening in Correctional Facilities. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada.
    [7] 19. Johnston J (2012) Active TB in Foreign Born Populations. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada.
    [8] 20. Soualhine H (2012) Molecular diagnostic tools for tuberculosis control. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada.
    [9] 21. World Health Organization (2013) Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational “how-to” practical considerations. World Health Organization, 2013. Available from: http://whqlibdoc. who. int/publications/2011/89241501569_eng. pdf. Web. 5 Jul 2013.
    [10] 22. Gardy J (2012) Quantifying Endogenous Transmission of TB in Canada: The Impact of Next-generation Genome Sequencing. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada.
    [11] 24. Rea E (2012) Video Directly Observed Therapy (VDOT). OPHA Annual Fall Forum 2012 eHealth Innovations in Public Health. Toronto: Ontario Public Health Associations.
    [12] 25. Centers for Disease Control and Prevention (2011) Morbidity and Mortality Weekly Report. Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection. MMWR 60(48): 1650-1653.
    [13] 26. Sterling TR, Elsa V, et al. (2011) Three Months of Rifapentine and Isoniazid for latent tuberculosis infection. N Engl J Med 365(23): 2155-2166.
    [14] 27. Rea E (2012) TB Control in Toronto. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada.
    [15] 28. Public Health Agency of Canada (2013) Tuberculosis in Canada 2010, Pre-Release. Public Health Agency of Canada, 2012. Available from: http://www. phac-aspc. gc. ca/tbpc-latb/pubs/tbcan10pre/index-eng. php. Web. 28 Nov 2013.
    [16] 29. Pottie K, Greenaway C, Feightner J, et al. (2011) Evidence-based clinical guidelines for immigrants and refugees. CMAJ 183(12):
    [17] 30. Varughese B (2012) Preventing Tuberculosis in the Foreign-Born Population of Canada: A Mathematical Modeling Study. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada.
    [18] 31. Turner G (2012) TB in Inuit Nunagat: From context to Inuit designed and led solutions. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada.
    [19] 32. MacLeod M, Browne AJ, Leipert B (8) Issues for nurses in rural and remote Canada. J Rural Health 6(2): 72-78.
    [20] 33. Health Council of Canada (3) Canada's most vulnerable: Improving health care for First Nations, Inuit, and Métis seniors. Health Council of Canada, 2013. Available from: http://www. hhr-rhs. ca/images/stories/Senior_AB_Report_2013_EN_final.
    [21] 34. Moffatt J, Maria M, Long (2013) Sanitoriums and the Canadian Colonial Legacy: The Untold Experiences of Tuberculosis Treatment. Qual Life Res 23(12): 1591-1599.
    [22] 35. Brassard P, Anderson KK, Menzies D, et al. (2008) Knowledge and Perceptions of Tuberculosis Among a Sample of Urban Aboriginal People. J Comm Health 33(4): 192-198.
    [23] 37. Rees S, Jocelyne C (2012) Health Canada's Strategy against Tuberculosis for First Nations On-Reserve. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada.
    [24] 38. Alvarez G (2012) TAIMA TB (STOP TB Inuktitut) in Iqaluit, Nunavut. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada.
    [25] 39. Gaetz S (2012) Homelessness, Social Exclusion, and the Risk of Tuberculosis Infection. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada.
    [26] 40. Ronald A (2012) Population Health in the 21st Century. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada.
    [27] 41. Du Y (2012) Mathematical Model for Tuberculosis at Different Scales. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada.
    [28] 42. Wigginton J, Kirschner D (2001) A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis. J Immunol 166(3): 1951-1976.
    [29] 43. Marino S, Kirschner DE (2004) The Human Immune Response to Mycobacterium tuberculosis in lung and lymph node. J Theor Biol 227(4): 463-486.
    [30] 44. Magombedze G, Garira W, Mwenje E (2006) Modelling the human immune response mechanisms to Mycobacterium tuberculosis infection in the lungs. Math Biosci Eng 3(4): 661.
    [31] 45. Alavez-Ramírez J, Castellanos JR, Esteva L, et al. (2007) Within-host population dynamics of antibiotic-resistant M. tuberculosis. Math Med Biol 24(1): 35-56.
  • Reader Comments
  • © 2014 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
AIMS Public Health
3.3 3.4

Metrics

Article views(4367) PDF downloads(1273) Cited by(0)

Preview PDF
Download XML
Export Citation
Article outline

Other Articles By Authors

Related pages

Tools

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog